Ligand validation:8WUE

ZWY: 17-oxoandrost-5-en-3beta-yl hydrogen sulfate

ZWY is a Ligand Of Interest in 8WUE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8WUE_ZWY_F_301	10%	64%	0.379	0.894	0.32	1.03	-	2	0	0	100%	1
8WUE_ZWY_E_301	8%	52%	0.42	0.896	0.47	1.36	-	3	0	0	100%	1
8WUE_ZWY_B_301	7%	54%	0.421	0.87	0.47	1.3	-	2	0	0	100%	1
8WUE_ZWY_A_301	6%	54%	0.476	0.914	0.33	1.4	-	6	0	0	100%	1
8WUE_ZWY_C_301	5%	52%	0.441	0.855	0.39	1.44	-	6	0	0	100%	1
8WUE_ZWY_D_301	1%	59%	0.654	0.856	0.26	1.29	-	4	0	0	100%	1
8WWB_ZWY_A_301	9%	65%	0.314	0.806	0.31	1.02	-	2	0	0	100%	1
8GK3_ZWY_D_606	81%	3%	0.125	0.979	2.46	3.72	11	21	0	0	100%	0.8268

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.